Skip to content

Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism

A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01675492
Enrollment
126
Registered
2012-08-30
Start date
2012-12-06
Completion date
2016-11-22
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Keywords

Astigmatism, refractive, error, LASIK

Brief summary

To demonstrate that wavefront-guided LASIK with measurements from iDesign is safe and effective in the treatment of mixed astigmatism.

Interventions

DEVICELASIK

Surgeons will perform wavefront-guided LASIK based upon measurements obtained with the iDesign System

Sponsors

Abbott Medical Optics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age at the time of pre-operative exam * Best Spectacle Corrected Visual Acuity (BSCVA) of 20/20 or better * Demonstration of refractive stability * Anticipated post-operative stromal bed thickness of at lest 250 microns * Willing and capable of returning for follow-up examinations for the duration of the study

Exclusion criteria

* Women who are pregnant, breast-feeding, or intend to become pregnant over the course of the study * Concurrent use of topical or systemic medications that may impair healing * History of any medical conditions that could affect wound healing * History of prior intraocular or corneal surgery, active ophthalmic disease,or other ocular abnormality * Evidence of keratoconus, corneal irregularity, or abnormal topography in the operative eye(s) * Known sensitivity or inappropriate responsiveness to any of the medications used in the post-operative course

Design outcomes

Primary

MeasureTime frameDescription
Line Loss of More Than Two Lines for Best Spectacle Corrected Visual Acuity (BSCVA)3 Months\< 5% of eyes will have a loss of \> 2 lines of BSCVA at any postoperative visit, as measured using ETDRS logMAR visual acuity charts at 4 meters

Secondary

MeasureTime frameDescription
Uncorrected Visual Acuity (UCVA) of 20/40 or Better3 Months85% of eyes will have UCVA of 20/40 or better, as measured using ETDRS logMAR charts at 4 meters

Participant flow

Participants by arm

ArmCount
Wave-front Guided LASIK
LASIK: Surgeons will perform wavefront-guided LASIK based upon measurements obtained with the iDesign System for mixed astigmatism refraction
84
Wave-front Guided LASIK
LASIK: Surgeons will perform wavefront-guided LASIK based upon measurements obtained with the iDesign System for mixed astigmatism refraction
149
Total233

Withdrawals & dropouts

PeriodReasonFG000
Overall Studystudy completed early - product approval42

Baseline characteristics

CharacteristicWave-front Guided LASIK
Age, Continuous36.3 years
STANDARD_DEVIATION 10.36
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
73 Participants
Region of Enrollment
United States
84 Participants
Sex: Female, Male
Female
39 Participants
Sex: Female, Male
Male
45 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 84
other
Total, other adverse events
0 / 84
serious
Total, serious adverse events
0 / 84

Outcome results

Primary

Line Loss of More Than Two Lines for Best Spectacle Corrected Visual Acuity (BSCVA)

\< 5% of eyes will have a loss of \> 2 lines of BSCVA at any postoperative visit, as measured using ETDRS logMAR visual acuity charts at 4 meters

Time frame: 3 Months

ArmMeasureValue (COUNT_OF_UNITS)
Wave-front Guided LASIKLine Loss of More Than Two Lines for Best Spectacle Corrected Visual Acuity (BSCVA)149 eyes
Secondary

Uncorrected Visual Acuity (UCVA) of 20/40 or Better

85% of eyes will have UCVA of 20/40 or better, as measured using ETDRS logMAR charts at 4 meters

Time frame: 3 Months

ArmMeasureValue (COUNT_OF_UNITS)
Wave-front Guided LASIKUncorrected Visual Acuity (UCVA) of 20/40 or Better149 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026